Orchestra BioMed Holdings, Inc. Number of Reportable Segments
Orchestra BioMed Holdings, Inc. (OBIO) reported Number of Reportable Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. number of reportable segments for the quarter ending 2026-03-31 was 1.00 segment, a 0.00% change year-over-year.
- Orchestra BioMed Holdings, Inc. number of reportable segments for the quarter ending 2025-03-31 was 1.00 segment.
- Orchestra BioMed Holdings, Inc. number of reportable segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
- Orchestra BioMed Holdings, Inc. number of reportable segments for fiscal 2024 was 1.00 segment.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-10 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-03-12 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-12 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-12 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2026-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |